Form 4 for RMD ResMed|
Accepted 2021-08-23 00:00:00 ET · period of report 2021-08-20 · accession 0001127602-21-024177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-23 | 2021-08-20 | RMD | Sandercock Brett | CFO | M - OptEx | $57.76 | +10.7K | 95.0K | +13% | +$620.1K |
| D | 2021-08-23 | 2021-08-20 | RMD | Sandercock Brett | CFO | S - Sale+OE | $281.73 | -10.7K | 89.8K | -11% | -$3.02M |
| DM | 2021-08-23 | 2021-08-20 | RMD | Sandercock Brett | CFO | M - OptEx | $0.00 | -10.7K | 35.5K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-08-20 | M | A | 5,543 | $57.76 | 100,522 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2021-08-20 | S | D | 10,736 | $281.73 | 89,786 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2021-08-20 | M | A | 5,193 | $57.76 | 94,979 | D | — | — | |
| 4 | Derivative | ResMed Common Stock Options | 2021-08-20 | M | D | 5,543 | $0.00 | 30,000 | D | $57.76 · 2017-11-11 to 2023-11-16 | 5,543 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |
| 5 | Derivative | ResMed Common Stock Options | 2021-08-20 | M | D | 5,193 | $0.00 | 35,543 | D | $57.76 · 2017-11-11 to 2023-11-16 | 5,193 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |